x
Filter:
Filters applied
- Coronavirus (COVID-19) Collection
- Rapid CommunicationRemove Rapid Communication filter
- Mattar, SalimRemove Mattar, Salim filter
Publication Date
Please choose a date range between 2020 and 2021.
Author
- Alvis Guzman, Nelson1
- Arrieta, Germán1
- Botero, Yesica1
- Brango, Eimi1
- Contreras, Hector1
- Contreras, Veronica1
- de la Hoz Restrepo, Fernando1
- Faccini-Martínez, Álvaro A1
- Galeano, Ketty1
- Garay, Evelin1
- García, Alejandra1
- Gastelbondo, Bertha1
- Guzmán, Camilo1
- Kerguelen, Hugo1
- Martínez, Caty1
- Miranda, Jorge1
- Moscote, Maria1
- Rivero, Ricardo1
- Serrano-Coll, Hector1
Coronavirus (COVID-19) Collection
2 Results
- Short CommunicationOpen Access
Using serological studies to assess COVID-19 infection fatality rate in developing countries: A case study from one Colombian department
International Journal of Infectious DiseasesVol. 110p4–5Published online: June 11, 2021- Nelson Alvis Guzman
- Fernando De la Hoz Restrepo
- Hector Serrano-Coll
- Bertha Gastelbondo
- Salim Mattar
Cited in Scopus: 2The infection fatality rate (IFR) is a critical epidemiological parameter that allows assessment of the dynamics and virulence of any infectious agent and the quality of health services (Levin et al., 2020). There is still uncertainty about the true IFR of COVID-19 because detecting all infections and cases depends on the quality of surveillance and the number of tests available. Attempting to estimate IFR in developing countries is incredibly challenging because they have weaker surveillance systems coupled with a deficit of laboratories able to carry out molecular tests across the entire territory. - Short CommunicationOpen Access
Serological cross-reactivity using a SARS-CoV-2 ELISA test in acute Zika virus infection, Colombia
International Journal of Infectious DiseasesVol. 101p191–193Published online: September 27, 2020- Álvaro A. Faccini-Martínez
- Ricardo Rivero
- Evelin Garay
- Alejandra García
- Salim Mattar
- Yesica Botero
- and others
Cited in Scopus: 20Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the etiological agent of coronavirus disease-2019 (COVID-19), an emerging zoonotic viral disease responsible for an ongoing pandemic (Chams et al., 2020). The infection has spread globally, with 31,167,374 confirmed cases and 962,046 related deaths as on September 21, 2020 (https://coronavirus.jhu.edu/map.html). Clinically, according to a recent systematic review with meta-analysis, in patients with COVID-19, fever was the most prevalent clinical manifestations (88.7%, 95% CI 84.5–92.9%), followed by respiratory symptoms such as cough and dyspnea, which could be present in less than 60% of the patients (Rodriguez-Morales et al., 2020).
